Hydrogen-rich saline promotes survival of retinal ganglion cells in a rat model of optic nerve crush.
Jing-chuan Sun, Tao Xu, Qiao Zuo, Ruo-bing Wang, Ai-qing Qi, Wen-luo Cao, Ai-jun Sun, Xue-jun Sun, Jiajun Xu · PloS one · 2014
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In rats, h&E, gamma synuclein staining and CTB tracing showed that the survival rate of RGCs in hydrogen saline-treated group was significantly higher than that in saline-treated group. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in rats. H&E, gamma synuclein staining and CTB tracing showed that the survival rate of RGCs in hydrogen saline-treated group was significantly higher than that in saline-treated group.
What the Researchers Studied
The researchers studied rats. The study used a preclinical animal experiment. The comparison condition was placebo.
What Effects Did Molecular Hydrogen Have?
Reported treatment duration: 14 days. H&E, gamma synuclein staining and CTB tracing showed that the survival rate of RGCs in hydrogen saline-treated group was significantly higher than that in saline-treated group. The authors concluded that these results demonstrated that H₂ protects RGCs and helps preserve the visual function after ONC and had a neuroprotective effect in a rat model subjected to ONC. In a study of Alzheimer's disease, hydrogen saline was demonstrated to decrease oxidative neuronal stress by reducing malondialdehyde (MDA, biomarker of lipid peroxidation) and 4-hydroxynonenal (HNE, biomarker of arachidonic acid peroxidation) [25].
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was rats. The study used a preclinical animal experiment. The reported treatment duration was 14 days.
Limitations and Safety
Safety information: Due to its efficacy, safety, and convenience, H₂ saline may be a potential therapy for TON in the future.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.